REFERENCES
- Pui C H, Crist W M. Treatment of childhood leukemias. Curr Opin Oncol. 1995; 7: 36–44. [PUBMED], [INFOTRIEVE]
- Hongo T, Yajima S, Sakurai M, et al, In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood. 1991; 89: 2959–2965
- Kaspers G JL, Veerman A J, Pieters R. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 1997; 90: 2723–2729. [PUBMED], [INFOTRIEVE]
- Boyum H C. Isolation of leucocytes from human blood: further observations. Scand J Clin Lab Invest. 1968; 21(Suppl)31–50
- Klumper E, Pieters R, Den Boer M L, et al, In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia. Br J Cancer. 1995; 71: 1188–93. [PUBMED], [INFOTRIEVE]
- Srinivas G, Kusumakumary P, Nair M K, Panicker K R, Pillai M R. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia. J Cancer Res Clin Oncol. 2000; 126: 62–67. [PUBMED], [INFOTRIEVE]
- Krajewski S, Blomqvist C, Franssila K, et al, Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 1995; 55: 4471–4478. [PUBMED], [INFOTRIEVE]
- Wattel E, Guerci A, Hecquet B, et al, A randomized trial of hydroxyurea (HY) versus VP16 in advanced adult chronic myelomonocytic leukemia. Leuk Res. 1994; 18(Suppl 21)
- Campos L, Rouault J P, Sabido O, et al, High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 1993; 81: 3091–3096. [PUBMED], [INFOTRIEVE]
- Miyashita T, Reed J C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood. 1993; 81: 151–157. [PUBMED], [INFOTRIEVE]
- Pieters R, Huismans D R, Loonen A H, et al, Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia. Lancet. 1991; 338: 399–403. [PUBMED], [INFOTRIEVE]
- Norgaard J M, Jensen P D, Bendix K, et al, Relevance of in vitro leukaemia cell survival to short- and long-term clinical outcome in AML. Leuk Lymphoma. 1999; 32: 327–337. [PUBMED], [INFOTRIEVE]
- Salomons G S, Smets L A, Verwijs-Janssen M, et al, Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia. 1999; 13: 1574–1580. [PUBMED], [INFOTRIEVE]
- Mihal V, Hajduch M, Noskova V, et al, Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells. Adv Exp Med Biol. 1999; 457: 461–471. [PUBMED], [INFOTRIEVE]